Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Immunomedics Inc (IMMU)

8.42 +0.44 (+5.51%)

8/18/2017  4:00pm

Open:

7.89

Pre. Close:

7.98

High:

8.43

Low:

7.68

Volume:

3,069,139

Market Cap:

936.97M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

8.53 - 8.67

8.67 - 8.86

Low:

7.35 - 7.45

7.45 - 7.58

Close:

8.18 - 8.42

8.42 - 8.73

Technical analysis  (as of: 2017-08-18 4:41:50 PM)

Overall:

      

Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 10.85     One year: 12.67

Support:

Support1: 7.98    Support2: 7.17

Resistance:

Resistance1: 9.29    Resistance2: 10.85

Pivot:

8.15

Moving Averages:

MA(5): 8.02     MA(20): 8.29

MA(100): 7.51     MA(250): 5.26

MACD:

MACD(12,26): -0.13     Signal(12,26,9): -0.11

%K %D:

%K(14,3): 44.26     %D(3): 32.44

RSI:

RSI(14): 52.68

52-Week:

High: 9.51  Low: 2.02  Change(%): 182.6

Average Vol(K):

3-Month: 190508  10-Days 50802

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
IMMU has closed below upper band by 24.7%. Bollinger Bands are 25.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 18 Aug 2017 16:30:00 GMT
Buy or Sell? What Analysts Recommends: Immunomedics, Inc. (IMMU), LendingClub ...

Tue, 15 Aug 2017 18:45:00 GMT
Checking the Overall Picture for Immunomedics, Inc. (IMMU)

Tue, 01 Aug 2017 18:56:15 GMT
Immunomedics, Inc. (IMMU): What's the Story?

Thu, 17 Aug 2017 13:43:01 GMT
Valeant Pharmaceuticals Intl Inc's Glaucoma Drug Could Be A Blockbuster ...

Fri, 04 Aug 2017 14:15:00 GMT
The Case for and Against Immunomedics, Inc. (IMMU)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

110.30

Shares Float (M)

90.28

% Held by Insiders

6.84

% Held by Institutions

43.70

Shares Short (K)

25460

Shares Short Prior Month (K)

33780

Stock Financials

EPS

-1.150

EPS Est. Current Year

-1.070

EPS Est. Next Year

-0.560

EPS Est. Next Quarter

-0.060

Forward EPS

-0.560

Book Value (p.s.)

-1.200

PEG Ratio

Profit Margin

Operating Margin

-1912.17

Return on Assets (ttm)

-67.2

Return on Equity (ttm)

Qtrly Rev. Growth

47.2

Gross Profit (p.s.)

0.019

Sales Per Share

EBITDA (p.s.)

-0.578

Qtrly Earnings Growth

Operating Cash Flow (M)

-60.73

Levered Free Cash Flow (M)

31.16

FoxReading.com

Valuation

P/E

-7.32

P/E Growth Ratio

0.06

P/BV

-7.02

P/S

30957533184.00

P/CF

-15.29

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2015-01-12

Ex-Dividend Date

2015-10-11

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.